Related references
Note: Only part of the references are listed.ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
Linus A. Voelker et al.
BLOOD ADVANCES (2020)
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Linus A. Voelker et al.
BLOOD ADVANCES (2020)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Injection Site Reactions to PCSK9i Monoclonal Antibody Therapies are caused by Polysorbates in the Products
Craig Stark et al.
Journal of Clinical Lipidology (2018)
An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity
S Limaye et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Share Paper
